Aventus Thrombectomy System Pulmonary Embolism Clinical Study

NACompletedINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

September 20, 2023

Primary Completion Date

February 20, 2025

Study Completion Date

February 20, 2025

Conditions
Pulmonary EmbolismEmbolismEmbolism and ThrombosisVascular DiseasesCardiovascular DiseasesLung DiseasesRespiratory Tract Diseases
Interventions
DEVICE

Thrombectomy

Use of Aventus Thrombectomy System to treat pulmonary embolism

Trial Locations (26)

10019

Ichan School of Medicine at Mount Sinai, New York

20010

Medstar, Washington D.C.

30322

Emory University, Atlanta

37203

Centennial Medical Center (HCA), Nashville

43214

OhioHealth Research Institute, Columbus

43606

ProMedica - Jobst Vascular, Toledo

44106

University Hospitals, Cleveland

46260

Ascension St. Vincent, Indianapolis

48075

Ascension Providence, Southfield

48202

Henry Ford Hospital, Detroit

48708

McLaren Health Care, Bay City

56303

CentraCare Heart and Vascular, Saint Cloud

60007

Alexian Brothers Medical Center, Elk Grove Village

60611

Northwestern University, Chicago

70121

Ochsner Health, New Orleans

74006

Ascension St. John, Tulsa

78705

Ascension Seton, Austin

85258

Honor Health, Scottsdale

90806

MemorialCare, Long Beach

94040

El Camino Health, Mountain View

94533

NorthBay Medical Center, Fairfield

95816

Sutter Health, Sacramento

06102

Hartford Hospital, Hartford

07601

Hackensack University Medical Center, Hackensack

07666

Holy Name Medical Center, Teaneck

02906

The Miriam Hospital, Providence

Sponsors
All Listed Sponsors
lead

Inquis Medical, Inc.

INDUSTRY

NCT05907564 - Aventus Thrombectomy System Pulmonary Embolism Clinical Study | Biotech Hunter | Biotech Hunter